Abpro
Developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases.
Woburn, United States
39 employees
Venture round
Total: $40.39M
Biotechnology, Health Care +1
General Information
Woburn, United States
BounceWatch is an independent company data service, not affiliated with Abpro . To contact Abpro , visit abpro.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Abpro
Taxonomy: Antibody Therapeutics, Immuno-Oncology, Ophthalmology, Reagents, Biochemistry, Recombinant Proteins, Collaborations, Therapeutic Antibodies, Cancer Research, Infectious Diseases, T-Cell Engagers, Wet AMD, DME, Bi-Specific Antibodies
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $18.00M | - |
|
27 Jan 2020 |
| Venture Round | $10.00M | - |
|
07 Apr 2017 |
| Venture Round | $12.39M | - |
|
23 Mar 2016 |
Abpro Alternatives & Competitors
Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guideline...
Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and di...
Innovation Focused Outcomes Driven
FAQ About Abpro
Source: BounceWatch company record for Abpro , https://bouncewatch.com/company/abpro, updated 4 January 2025. When citing, please name BounceWatch and link this page.
